Role for Akt3/protein kinase Bgamma in attainment of normal brain size - PubMed (original) (raw)
. 2005 Mar;25(5):1869-78.
doi: 10.1128/MCB.25.5.1869-1878.2005.
Han Cho, Kristin Roovers, Diana W Shineman, Moshe Mizrahi, Mark S Forman, Virginia M-Y Lee, Matthias Szabolcs, Ron de Jong, Tilman Oltersdorf, Thomas Ludwig, Argiris Efstratiadis, Morris J Birnbaum
Affiliations
- PMID: 15713641
- PMCID: PMC549378
- DOI: 10.1128/MCB.25.5.1869-1878.2005
Role for Akt3/protein kinase Bgamma in attainment of normal brain size
Rachael M Easton et al. Mol Cell Biol. 2005 Mar.
Abstract
Studies of Drosophila and mammals have revealed the importance of insulin signaling through phosphatidylinositol 3-kinase and the serine/threonine kinase Akt/protein kinase B for the regulation of cell, organ, and organismal growth. In mammals, three highly conserved proteins, Akt1, Akt2, and Akt3, comprise the Akt family, of which the first two are required for normal growth and metabolism, respectively. Here we address the function of Akt3. Like Akt1, Akt3 is not required for the maintenance of normal carbohydrate metabolism but is essential for the attainment of normal organ size. However, in contrast to Akt1-/- mice, which display a proportional decrease in the sizes of all organs, Akt3-/- mice present a selective 20% decrease in brain size. Moreover, although Akt1- and Akt3-deficient brains are reduced in size to approximately the same degree, the absence of Akt1 leads to a reduction in cell number, whereas the lack of Akt3 results in smaller and fewer cells. Finally, mammalian target of rapamycin signaling is attenuated in the brains of Akt3-/- but not Akt1-/- mice, suggesting that differential regulation of this pathway contributes to an isoform-specific regulation of cell growth.
Figures
FIG. 1.
Generation of Akt3-deficient mice. (A) Diagram of the Akt3 genomic locus and the targeting vector. The positions of the Southern probe (probe) and PCR primers (1, 2, and 3) are indicated. (B) Genomic DNAs isolated from wild-type (+/+), Akt3 heterozygous (+/−), and _Akt3_-null (−/−) mice were digested with EcoRI and analyzed by Southern blotting. (C) PCR analysis of genomic DNAs from wild-type (+/+), Akt3 heterozygous (+/−), and _Akt3_-null (−/−) mice. Primers 1 and 2 generate a 650-bp band from wild-type DNA, and primers 1 and 3 generate a 700-bp band from DNA with a targeted Akt3 allele.
FIG. 2.
Akt protein expression. (A) Tissues from three adult female wild-type mice were isolated for protein analysis. The amount of Akt3 protein in each tissue relative to the amount in the wild-type brain is depicted, and a representative Western blot is shown. Data for brains isolated from adult Akt1 (1KO)-, Akt2 (2KO)-, and Akt3 (3KO)-deficient mice are shown for comparison. The graph represents means ± SD for three blots. (B) Brains were dissected from three adult wild-type C57BL/6 mice, and the cortices, hippocampusi, and cerebella were isolated and homogenized for Akt protein measurements. Two dilutions (10 μg [a] and 20 μg [b]) from each sample were subjected to Western blot analysis. A standard curve of the recombinant protein for each isoform was used to quantify the amount of Akt in the lysate (as detailed in Materials and Methods). The mean amounts of protein in the two dilutions and the standard deviations are depicted by the bar graph, and a representative Western blot is shown below.
FIG. 3.
Selective reduction of brain size in Akt3-deficient mice. (A) Brains were dissected from 30-week-old wild-type (WT) and Akt3-deficient (3KO) mice. (B) Plot of adult brain weights from Akt3 knockout mice and littermate controls (N = 6 or 7). The mean value is shown by a horizontal red bar. The asterisk indicates that P < 0.001 for wild-type versus Akt3-deficient brains. Male (C) and female (D) mice were weighed periodically during the first 8 weeks of life. Filled circles represent wild-type mice; open circles depict Akt3-deficient mice. Values are means ± standard errors of the means (SEM) (N = 15 to 20).
FIG. 4.
Allometric plot. A log-log plot with first-order regression of the brain weights (BR) of wild-type and Akt3 knockout mice versus their corresponding body weights (BW) determined at postnatal days 3, 7, 12, 16, 20, 21, and 23 is shown. The results of the corresponding regression analyses were as follows: for wild-type mice, BR = 0.08BW0.75 (r = 0.97); for Akt3 knockout mice, BR = 0.09BW0.61 (r = 0.98).
FIG. 5.
Cell size in the Akt3-deficient brain. (A and B) Sections of cortex stained with Hoechst 33258. Bar = 100 μm. (C) Mean cell areas based on nuclear densities. *, P < 0.001 for Akt3 knockout (KO) versus wild-type (WT) brains.
FIG. 6.
Metabolism in Akt3-deficient mice. (A and B) Glucose tolerance tests were performed with male (A) and female (B) mice as described in Materials and Methods. Values represent means ± SEM (N = 8 to 10). Filled squares represent wild-type mice; open squares depict Akt3-deficient mice. (C and D) Insulin tolerance tests were performed with male (C) and female (D) mice as described in Materials and Methods. Values represent means ± SEM (N = 8 to 10). Filled squares represent wild-type mice; open squares depict Akt3-deficient mice.
FIG. 7.
Cell size in Akt1-deficient brains and hearts. (A and B) Sections of cortex stained with Hoechst 33258. Bar = 50 μm. (C) Mean cell areas based on nuclear densities. (D and E) Micrographs of sections of hearts from Akt1 knockout mice (E) and littermate controls (D) were stained with FITC-conjugated wheat germ agglutinin (green) and propidium iodide (red). (F) The mean cell area of cardiomyocytes is represented as a percentage of the mean wild-type control value. Values are means ± SD (N = 3). *, P < 0.01 for Akt1 knockout myocyte size versus wild-type control size.
FIG. 8.
Phosphorylation of ribosomal protein S6 in brains from Akt-deficient mice. (A and C) Lysates (25 μg) from postnatal day 1 brains were resolved by SDS-PAGE, transferred to a nitrocellulose membrane, and probed for phosphorylated ribosomal protein S6 (P-S6) or total S6 ribosomal protein as indicated. Each lane represents a lysate from an individual animal. (B and D) The intensities of phosphorylated ribosomal protein S6 from several experiments were normalized to that of the total S6 ribosomal protein and expressed as percentages of the mean wild-type value. The data shown are means ± SD (N = 3 to 6). *, P < 0.01 for Akt3 knockout versus wild-type littermates.
Similar articles
- Life with a single isoform of Akt: mice lacking Akt2 and Akt3 are viable but display impaired glucose homeostasis and growth deficiencies.
Dummler B, Tschopp O, Hynx D, Yang ZZ, Dirnhofer S, Hemmings BA. Dummler B, et al. Mol Cell Biol. 2006 Nov;26(21):8042-51. doi: 10.1128/MCB.00722-06. Epub 2006 Aug 21. Mol Cell Biol. 2006. PMID: 16923958 Free PMC article. - Oncogenic transformation induced by membrane-targeted Akt2 and Akt3.
Mende I, Malstrom S, Tsichlis PN, Vogt PK, Aoki M. Mende I, et al. Oncogene. 2001 Jul 19;20(32):4419-23. doi: 10.1038/sj.onc.1204486. Oncogene. 2001. PMID: 11466625 - Essential role of protein kinase B gamma (PKB gamma/Akt3) in postnatal brain development but not in glucose homeostasis.
Tschopp O, Yang ZZ, Brodbeck D, Dummler BA, Hemmings-Mieszczak M, Watanabe T, Michaelis T, Frahm J, Hemmings BA. Tschopp O, et al. Development. 2005 Jul;132(13):2943-54. doi: 10.1242/dev.01864. Epub 2005 Jun 1. Development. 2005. PMID: 15930105 - Functional and therapeutic significance of Akt deregulation in malignant melanoma.
Robertson GP. Robertson GP. Cancer Metastasis Rev. 2005 Jun;24(2):273-85. doi: 10.1007/s10555-005-1577-9. Cancer Metastasis Rev. 2005. PMID: 15986137 Review. - Activation of AKT kinases in cancer: implications for therapeutic targeting.
Bellacosa A, Kumar CC, Di Cristofano A, Testa JR. Bellacosa A, et al. Adv Cancer Res. 2005;94:29-86. doi: 10.1016/S0065-230X(05)94002-5. Adv Cancer Res. 2005. PMID: 16095999 Review.
Cited by
- Substrate preference of protein kinase B isoforms can vary depending on the cell line.
Palma MS, Perez SR, Husain A, Bhandari D. Palma MS, et al. PLoS One. 2024 Mar 19;19(3):e0298322. doi: 10.1371/journal.pone.0298322. eCollection 2024. PLoS One. 2024. PMID: 38502658 Free PMC article. - Revving the engine: PKB/AKT as a key regulator of cellular glucose metabolism.
Li X, Hu S, Cai Y, Liu X, Luo J, Wu T. Li X, et al. Front Physiol. 2024 Jan 8;14:1320964. doi: 10.3389/fphys.2023.1320964. eCollection 2023. Front Physiol. 2024. PMID: 38264327 Free PMC article. Review. - Rett and Rett-related disorders: Common mechanisms for shared symptoms?
D'Mello SR. D'Mello SR. Exp Biol Med (Maywood). 2023 Nov;248(22):2095-2108. doi: 10.1177/15353702231209419. Epub 2023 Dec 6. Exp Biol Med (Maywood). 2023. PMID: 38057990 Free PMC article. Review. - Adrenergic receptors blockade alleviates dexamethasone-induced neurotoxicity in adult male Wistar rats: Distinct effects on β-arrestin2 expression and molecular markers of neural injury.
Mohamed RMSM, Ahmad Ahmad E, Amin DM, Abdo SA, Ibrahim IAAE, Mahmoud MF, Abdelaal S. Mohamed RMSM, et al. Daru. 2024 Jun;32(1):97-108. doi: 10.1007/s40199-023-00490-y. Epub 2023 Nov 15. Daru. 2024. PMID: 37966585 Free PMC article. - Phenyl-2-aminoethyl selenide ameliorates hippocampal long-term potentiation and cognitive deficits following doxorubicin treatment.
Alhowail AH, Eggert M, Bloemer J, Pinky PD, Woodie L, Bhattacharya S, Bhattacharya D, Buabeid MA, Smith B, Dhanasekaran M, Piazza G, Reed MN, Escobar M, Arnold RD, Suppiramaniam V. Alhowail AH, et al. PLoS One. 2023 Nov 10;18(11):e0294280. doi: 10.1371/journal.pone.0294280. eCollection 2023. PLoS One. 2023. PMID: 37948406 Free PMC article.
References
- Araki, E., M. A. Lipes, M. E. Patti, J. C. Bruning, B. Haag III, R. S. Johnson, and C. R. Kahn. 1994. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372:186-190. - PubMed
- Backman, S. A., V. Stambolic, A. Suzuki, J. Haight, A. Elia, J. Pretorius, M. S. Tsao, P. Shannon, B. Bolon, G. O. Ivy, and T. W. Mak. 2001. Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease. Nat. Genet. 29:396-403. - PubMed
- Bae, S. S., C. Han, J. Mu, and M. J. Birnbaum. 2003. Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B. J. Biol. Chem. 278:49530-49536. - PubMed
- Baker, J., J. P. Liu, E. J. Robertson, and A. Efstratiadis. 1993. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73-82. - PubMed
- Barthel, A., K. Nakatani, A. A. Dandekar, and R. A. Roth. 1998. Protein kinase C modulates the insulin-stimulated increase in Akt1 and Akt3 activity in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 243:509-513. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P01 CA097403/CA/NCI NIH HHS/United States
- DK50306/DK/NIDDK NIH HHS/United States
- P30 DK050306/DK/NIDDK NIH HHS/United States
- R01 DK056886/DK/NIDDK NIH HHS/United States
- T32 DK7314/DK/NIDDK NIH HHS/United States
- R01 DK56886/DK/NIDDK NIH HHS/United States
- DK19525/DK/NIDDK NIH HHS/United States
- T32 DK007314/DK/NIDDK NIH HHS/United States
- P30 DK019525/DK/NIDDK NIH HHS/United States
- P01 CA97403/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous